These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33213096)

  • 1. Genomic and Transcriptomic Analysis for Identification of Genes and Interlinked Pathways Mediating Artemisinin Resistance in
    Ghosh S; Verma A; Kumar V; Pradhan D; Selvapandiyan A; Salotra P; Singh R
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33213096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani.
    Verma A; Bhandari V; Deep DK; Sundar S; Dujardin JC; Singh R; Salotra P
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):370-377. PubMed ID: 29035735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance.
    Zheng Z; Chen J; Ma G; Satoskar AR; Li J
    Parasit Vectors; 2020 Oct; 13(1):510. PubMed ID: 33046138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-resistant Leishmania parasite modulates host cell defense mechanism and exhibits altered expression of unfolded protein response genes.
    Verma A; Ghosh S; Salotra P; Singh R
    Parasitol Res; 2019 Sep; 118(9):2705-2713. PubMed ID: 31359134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
    Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
    Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the copy number of Ldrab6 gene in Leishmania donovani parasites mediates drug resistance through drug-thiol conjugate dependent multidrug resistance protein A (MRPA).
    Chauhan IS; Rao GS; Singh N
    Acta Trop; 2019 Nov; 199():105158. PubMed ID: 31491399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani.
    Potvin JE; Leprohon P; Queffeulou M; Sundar S; Ouellette M
    Clin Infect Dis; 2021 May; 72(10):e526-e532. PubMed ID: 32827255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic insights into virulence mechanisms of Leishmania donovani: evidence from an atypical strain.
    Samarasinghe SR; Samaranayake N; Kariyawasam UL; Siriwardana YD; Imamura H; Karunaweera ND
    BMC Genomics; 2018 Nov; 19(1):843. PubMed ID: 30486770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and Phenotypic Characterization of Experimentally Selected Resistant Leishmania donovani Reveals a Role for Dynamin-1-Like Protein in the Mechanism of Resistance to a Novel Antileishmanial Compound.
    Hefnawy A; Negreira G; Jara M; Cotton JA; Maes I; D'Haenens E; Imamura H; Cuypers B; Monsieurs P; Mouchtoglou C; De Winter H; Pintelon I; Timmermans JP; Berriman M; Sanders M; Martin J; de Muylder G; Dujardin JC; Sterckx YG; Domagalska MA
    mBio; 2022 Feb; 13(1):e0326421. PubMed ID: 35012338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
    Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
    Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome wide comparison of Ethiopian Leishmania donovani strains reveals differences potentially related to parasite survival.
    Zackay A; Cotton JA; Sanders M; Hailu A; Nasereddin A; Warburg A; Jaffe CL
    PLoS Genet; 2018 Jan; 14(1):e1007133. PubMed ID: 29315303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Abengózar MA; Viamontes CG; Sarro J; Stephens MT; Pfrender ME; Rivas L; Morales MA
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4089-100. PubMed ID: 27114280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
    Decuypere S; Vanaerschot M; Brunker K; Imamura H; Müller S; Khanal B; Rijal S; Dujardin JC; Coombs GH
    PLoS Negl Trop Dis; 2012; 6(2):e1514. PubMed ID: 22389733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect.
    Chauhan IS; Marwa S; Rao GS; Singh N
    Parasitol Res; 2020 Sep; 119(9):2991-3003. PubMed ID: 32748038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani.
    Kulshrestha A; Sharma V; Singh R; Salotra P
    Parasitol Res; 2014 Mar; 113(3):1171-84. PubMed ID: 24449447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.
    Kothari H; Kumar P; Sundar S; Singh N
    Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis reveals allelic variation and chromosome copy number variation in paromomycin-resistant Leishmania donovani.
    Ghosh S; Kumar V; Verma A; Sharma T; Pradhan D; Selvapandiyan A; Salotra P; Singh R
    Parasitol Res; 2022 Nov; 121(11):3121-3132. PubMed ID: 36056959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.